A new trading day began on Monday, with Wave Life Sciences Ltd (NASDAQ: WVE) stock price down -6.26% from the previous day of trading, before settling in for the closing price of $8.62. WVE’s price has ranged from $4.25 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 607.85% over the last five years. Meanwhile, its annual earnings per share averaged -36.01%. With a float of $122.54 million, this company’s outstanding shares have now reached $153.04 million.
The firm has a total of 288 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.69%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.16%, while institutional ownership is 79.48%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.79% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Here are Wave Life Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Analysing the last 5-days average volume posted by the [Wave Life Sciences Ltd, WVE], we can find that recorded value of 1.95 million was better than the volume posted last year of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 5.37%. Additionally, its Average True Range was 0.76.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 1.82%, which indicates a significant decrease from 5.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.49% in the past 14 days, which was higher than the 70.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.68, while its 200-day Moving Average is $9.79. Now, the first resistance to watch is $8.35. This is followed by the second major resistance level at $8.61. The third major resistance level sits at $8.83. If the price goes on to break the first support level at $7.87, it is likely to go to the next support level at $7.65. Should the price break the second support level, the third support level stands at $7.39.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
With a market capitalization of 1.24 billion, the company has a total of 153,486K Shares Outstanding. Currently, annual sales are 108,300 K while annual income is -97,010 K. The company’s previous quarter sales were 83,750 K while its latest quarter income was 29,250 K.
